Sign In
Buy RHHBY
$49.06
-0.130 (-0.264%)
At Close: Jun 03, 2026
David Roche: U.S. dollar is likely to drop another 15-20%, causing a sell-off of treasuries
03:16am, Tuesday, 29'th Apr 2025
David Roche of Quantum Strategy says a weaker dollar will drive 10-year yields to 5.5%, which will threaten the dollar's dominance. He says the Fed can do little to prevent this selling of treasuries.
3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.
07:28am, Monday, 28'th Apr 2025
Amid recession worries and tumbling markets; President Trump's tariffs are still helping the U.S. economy achieve key wins. Many huge corporations have announced plans to invest billions in U.S. manuf
Roche: Key Products Stall, Obesity Pipeline Takes Shape
10:04am, Friday, 25'th Apr 2025
Roche's Q1 revenues beat Street consensus, but key growth products underperformed, making the beat less appealing. Mid-sized products like Phesgo, Xolair, and Polivy drove the revenue beat, compensati
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the New England Journal of Medicine (NEJM) has published a detail
Basel, 25 April 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the New England Journal of Medicine (NEJM) has published a detailed analysis of the phase III CENTERSTONE trial of Xoflu
Roche Holding AG (RHHBY) Q1 2025 Sales/ Trading Statement Call Transcript
05:53pm, Thursday, 24'th Apr 2025
Roche Holding AG (OTCQX:RHHBY) Q1 2025 Sales/ Trading Statement Call April 24, 2025 8:00 AM ET Company Participants Thomas Schinecker - Chief Executive Officer Alan Hippe - Chief Financial & Informati
Roche's Q1 Sales Increase Y/Y on Solid Performance of Key Drugs
12:40pm, Thursday, 24'th Apr 2025
RHHBY records impressive first-quarter 2025 performance on the back of strong demand for key drugs. The company confirms 2025 guidance.
Roche CEO says his team is in touch with White House directly over tariffs
05:21am, Thursday, 24'th Apr 2025
Roche is seeking relief from US import tariffs, arguing that its exports of American-made drugs and diagnostics offset the value of products it ships into the country. Reporting a conference call wit
Roche seeks US tariff relief in direct talks with Trump administration
03:46am, Thursday, 24'th Apr 2025
Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products it ships into the United States are offset by its exports of U.S.-made drugs
Roche Sales Rise, Boosted By Key Drugs
01:28am, Thursday, 24'th Apr 2025
Roche posted higher sales that beat analysts' expectations on higher demand for its key drugs.
Roche says Q1 sales up 7%, confirms guidance
01:09am, Thursday, 24'th Apr 2025
Swiss drugmaker Roche said on Thursday its first-quarter sales rose 7% to 15.44 billion Swiss francs ($18.64 billion) and it confirmed its full-year guidance.
Roche receives CE Mark for its Chest Pain Triage algorithm to enhance detection of Acute Coronary Syndrome (ACS)
01:00am, Wednesday, 23'rd Apr 2025
Basel, 23 April 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the introduction of its innovative Chest Pain Triage algorithm as part of the navifyⓇ Algorithm Suite. This groundbreaking a
Swiss Pharma Giant Roche To Invest $50B in US Amid Tariff Threat
08:41am, Tuesday, 22'nd Apr 2025
Swiss drugmaker Roche said it plans to invest $50 billion in the U.S., the latest in a string of large companies boosting their presence in the country since President Donald Trump came into office.
Drugmaker Roche pledges $50bn of US investment over five years
04:04am, Tuesday, 22'nd Apr 2025
Swiss pharma giant Roche said it will invest US$50 billion into the US in the next five years to ensure it exports more medicines from the country than it imports, amid threats of potential tariffs on
Roche to invest $50 billion in the U.S. as tariff threat lingers
03:09am, Tuesday, 22'nd Apr 2025
Swiss pharmaceutical giant Roche on Tuesday said that it would invest $50 billion in the United States.
